GENESIS THERAPEUTICS Trademark

Trademark Overview

On Wednesday, February 9, 2022, a trademark application was filed for GENESIS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the GENESIS THERAPEUTICS trademark a serial number of 97259016. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, August 27, 2024. This trademark is owned by Genesis Therapeutics, Inc.. The GENESIS THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of rare autoimmune and immune-system-related diseases and disorders; all of the foregoing excluding preparations for the treatment of ocular and opthalmic diseases and disorders
genesis therapeutics

General Information

Serial Number97259016
Word MarkGENESIS THERAPEUTICS
Filing DateWednesday, February 9, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, August 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 2, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of rare autoimmune and immune-system-related diseases and disorders; all of the foregoing excluding preparations for the treatment of ocular and opthalmic diseases and disorders
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 23, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenesis Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBurlingame, CA 940103117
Party NameGenesis Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlingame, CA 940103117

Trademark Events

Event DateEvent Description
Saturday, February 12, 2022NEW APPLICATION ENTERED
Monday, February 14, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 22, 2022ASSIGNED TO EXAMINER
Tuesday, November 22, 2022NON-FINAL ACTION WRITTEN
Tuesday, November 22, 2022NON-FINAL ACTION E-MAILED
Tuesday, November 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 22, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 22, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 23, 2023NON-FINAL ACTION WRITTEN
Tuesday, May 23, 2023NON-FINAL ACTION E-MAILED
Tuesday, May 23, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 23, 2023NON-FINAL ACTION WRITTEN
Tuesday, May 23, 2023NON-FINAL ACTION E-MAILED
Tuesday, May 23, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 9, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, August 9, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, November 22, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 22, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 24, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, November 27, 2023FINAL REFUSAL WRITTEN
Monday, November 27, 2023FINAL REFUSAL E-MAILED
Monday, November 27, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, February 27, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, February 27, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, May 24, 2024EXPARTE APPEAL RECEIVED AT TTAB
Friday, May 24, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, May 28, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 28, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 28, 2024EXPARTE APPEAL TERMINATED
Wednesday, June 12, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 24, 2024EX PARTE APPEAL-INSTITUTED

Related Keywords

therapeutics genesis disorders treatment diseases preparations pharmaceutical excluding foregoing ocular related opthalmic